[Clostridium difficile infecion--diagnostics, prevention and treatment]
- PMID: 24868904
[Clostridium difficile infecion--diagnostics, prevention and treatment]
Abstract
Clostridium difficile is the most common cause of an antibiotic-associated diarrhoea. Frequency of Clostridium difficile infections (CDI) increased in the last decade. This study presents current preventive measure i.e. hand washing, disposable gloves. Additionally, the article presents diagnostic methods: detection glutamine dehydrogenase (GDH), toxins A and B, cytotoxicity neutralization test, polymerase chain reaction methods (PCR) i.e. nucleic acid amplification test (NAAT) and stool culture. Moreover available methods of treatment were presented depending on severity of CDI e.i. metronidazole, vancomycin, fidaxomicin, rifaximin. Furthermore, the review provides information about alternative methods of treatment in view of new hypervirulent strains of C. difficile and increasing resistance to commonly used antibiotics, including: fuscid acid, bacitracin, probiotics, non-toxigenic strains, immunoglobulins, monoclonal antibodies, vaccines, toxins binders and fecal transplant.
Similar articles
-
Diagnosis and management of Clostridium difficile infection.Clin Gastroenterol Hepatol. 2013 Oct;11(10):1216-23; quiz e73. doi: 10.1016/j.cgh.2013.03.016. Epub 2013 Mar 28. Clin Gastroenterol Hepatol. 2013. PMID: 23542332 Review.
-
Clostridium difficile infection in older adults: a review and update on its management.Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Am J Geriatr Pharmacother. 2012. PMID: 22260856 Review.
-
Challenges and opportunities in the management of Clostridium difficile infection.Expert Rev Gastroenterol Hepatol. 2014 Nov;8(8):863-74. doi: 10.1586/17474124.2014.939630. Epub 2014 Jul 11. Expert Rev Gastroenterol Hepatol. 2014. PMID: 25012255 Review.
-
[Individualized treatment strategies for Clostridium difficile infections].Internist (Berl). 2017 Jul;58(7):675-681. doi: 10.1007/s00108-017-0268-2. Internist (Berl). 2017. PMID: 28589214 Review. German.
-
Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.J Hosp Infect. 2015 Jul;90(3):267-70. doi: 10.1016/j.jhin.2015.01.015. Epub 2015 Feb 9. J Hosp Infect. 2015. PMID: 25728208 Clinical Trial.